Regulatory T Cells Induce Metastasis by Increasing Tgf-β and Enhancing the Epithelial–Mesenchymal Transition

Eonju Oh1, JinWoo Hong2, Chae-Ok Yun3,4

  • 1Department of Bioengineering, College of Engineering, Hanyang University, 222 Wangsimni-ro, Seongdong-gu, Seoul 04763, Korea. djswn1111@hanyang.ac.kr.

Cells
|November 7, 2019
PubMed

Insights

Administering regulatory T cells (Tregs) to melanoma-bearing mice significantly increased lung metastasis. This was mediated by T cells enhancing melanoma cell invasion and migration via transforming growth factor-β (TGF-β) and epithelial-to-mesenchymal transition (EMT).

Area of Science:

  • Immunology
  • Oncology
  • Cancer Metastasis

Background:

  • Malignant melanoma is an aggressive skin cancer with frequent distant metastases.
  • The precise mechanisms driving melanoma metastasis remain incompletely understood.
  • Regulatory T cells (Tregs) play a role in immune suppression within the tumor microenvironment.

Purpose of the Study:

  • To investigate the role of exogenous regulatory T cells (Tregs) in promoting melanoma metastasis.
  • To elucidate the cellular and molecular mechanisms by which Tregs influence melanoma cell invasiveness and migration.

Main Methods:

  • Administration of exogenous Tregs to melanoma tumor-bearing mice (B16-BL6 model).
  • Assessment of lung metastasis following Treg administration.
  • Analysis of melanoma cell phenotype, including invasive and migratory capacity.
  • Measurement of transforming growth factor-β (TGF-β) expression and epithelial-to-mesenchymal transition (EMT) markers.
  • Evaluation of endogenous Treg recruitment into tumor tissues.

Main Results:

  • Exogenous Treg administration significantly increased lung metastasis in melanoma-bearing mice.
  • Cell-to-cell contact between melanoma cells and Tregs elevated TGF-β expression and induced EMT in melanoma cells.
  • Co-culture with Tregs enhanced melanoma cell migration, and Treg injection promoted endogenous Treg infiltration into tumors.

Conclusions:

  • Exogenous Tregs promote melanoma metastasis by enhancing cell invasiveness and migration.
  • Treg-mediated upregulation of TGF-β and induction of EMT are key mechanisms driving melanoma metastasis.
  • These findings highlight a novel role for Tregs in augmenting melanoma's metastatic potential.

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K